Cvs Daytime Cough Relief Chews - Citrus Punch

Description

CVS Dex Kids Daytime is a cough suppressant formulated for pediatric use. It is available in a package containing 16 doses. The product is designed to alleviate cough symptoms in children during the daytime.

Uses and Indications

This drug is indicated for the temporary relief of cough associated with minor throat and bronchial irritation, which may occur due to a cold.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The recommended dosage for adults and children aged 12 years and over is 2 chewable tablets every 4 hours, with a maximum limit of 12 chewable tablets within a 24-hour period. For children aged 6 to 12 years, the dosage is 1 chewable tablet every 4 hours, not to exceed 6 chewable tablets in a 24-hour period.

It is essential that the tablets are chewed thoroughly before swallowing to ensure proper absorption.

For children aged 6 years and under, the use of this medication is not recommended.

Healthcare professionals should advise patients to adhere strictly to the prescribed dosage and frequency, and to consult a physician if symptoms persist or worsen.

Contraindications

There are no specific contraindications identified for this product. However, it is essential to adhere to the recommended dosage guidelines, as exceeding the recommended dosage may lead to adverse effects.

Warnings and Precautions

It is imperative that this product not be used concurrently with prescription monoamine oxidase inhibitors (MAOIs), which are medications prescribed for depression, psychiatric disorders, emotional conditions, or Parkinson's disease. Additionally, this product should not be taken for a minimum of two weeks following the discontinuation of an MAOI. Healthcare professionals should advise patients to consult with their doctor or pharmacist if they are uncertain whether their prescription medication contains an MAOI.

Patients are instructed to discontinue use and seek medical advice if their cough persists for more than seven days, recurs, or is accompanied by symptoms such as fever, rash, or a persistent headache. These symptoms may indicate a more serious underlying condition that requires further evaluation.

Currently, there are no specific general precautions or laboratory tests associated with the use of this product. However, healthcare providers should remain vigilant and monitor patients for any adverse effects or complications that may arise during treatment.

Side Effects

Patients should be aware of the potential adverse reactions associated with this product. Serious adverse reactions may occur, particularly in individuals taking prescription monoamine oxidase inhibitors (MAOIs) for depression, psychiatric, or emotional conditions, or Parkinson's disease. The use of this product is contraindicated in patients currently taking an MAOI or within 2 weeks of discontinuing such medication. Patients are advised to consult a healthcare professional if they are uncertain whether their prescription includes an MAOI.

Common adverse reactions may include the need to discontinue use if cough persists for more than 7 days, tends to recur, or is accompanied by fever, rash, or persistent headache. These symptoms could indicate a serious underlying condition, warranting immediate medical attention.

Additionally, patients should seek medical advice before using this product if they have a sodium-restricted diet, experience a cough accompanied by excessive phlegm (mucus), or have a persistent or chronic cough, such as that associated with smoking, asthma, or emphysema.

Drug Interactions

The concomitant use of this product with prescription monoamine oxidase inhibitors (MAOIs) is contraindicated. MAOIs are typically prescribed for the treatment of depression, certain psychiatric conditions, or Parkinson's disease. Patients should not take this product while on MAOIs or for a minimum of two weeks following the discontinuation of an MAOI.

It is essential for patients to consult with a healthcare professional, such as a doctor or pharmacist, to verify whether their prescription medication contains an MAOI before initiating treatment with this product. This precaution is critical to avoid potential adverse effects associated with the interaction.

Packaging & NDC

Below are the non-prescription pack sizes of Cvs Daytime Cough Relief Chews - Citrus Punch (dextromethorphan hbr). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 6 to 12 years may receive 1 chewable tablet every 4 hours, with a maximum of 6 chewable tablets in a 24-hour period. The use of this medication is not recommended for children aged 6 years and under.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data on the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

There is no information available regarding renal impairment, dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise caution and consider individual patient factors when treating patients with renal impairment, as specific guidelines or recommendations are not provided.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdose, it is imperative to seek immediate medical assistance. Healthcare professionals are advised to contact a Poison Control Center at 1-800-222-1222 for guidance on managing the situation effectively.

Prompt intervention is crucial, as the symptoms of an overdose may vary depending on the substance involved. Therefore, a thorough assessment and appropriate management strategies should be implemented based on the specific clinical scenario presented.

Healthcare providers should ensure that they are prepared to provide supportive care and monitor the patient closely for any adverse effects that may arise from the overdose.

Nonclinical Toxicology

If pregnant or breastfeeding, it is advised to consult a health professional prior to use. There are no specific non-teratogenic effects or nonclinical toxicology details available. Additionally, no specific information regarding animal pharmacology and toxicology has been provided.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Patients should be advised to keep this product out of reach of children to prevent accidental ingestion. It is important to inform patients that they should stop using the product and consult a healthcare provider if their cough persists for more than 7 days, tends to recur, or is accompanied by symptoms such as fever, rash, or a persistent headache, as these may indicate a serious underlying condition.

Healthcare providers should emphasize the importance of adhering to the recommended dosage and caution patients against exceeding it. Additionally, patients should be encouraged to seek medical advice before using this product if they have a sodium-restricted diet, if their cough is accompanied by excessive phlegm (mucus), or if they have a persistent or chronic cough, which may occur with conditions such as smoking, asthma, or emphysema.

Storage and Handling

The product is supplied in a package configuration that includes NDC numbers relevant to its identification. It should be stored in a cool, dry place, maintaining a temperature range of 20° to 25°C (68° to 77°F). Proper storage conditions are essential to ensure the integrity and efficacy of the product.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Cvs Daytime Cough Relief Chews - Citrus Punch, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)